The pharmaceutical industry is not routinely making data from negative studies available through the published scientific literature or in available Internet sources. In the case of bipolar disorder, the negative unpublished data made available on lamotrigine provide an important context for clinical practice and research.
Medscape J Med. 2008;10(9):211 © 2008
Cite this: Publication Bias and the Pharmaceutical Industry: The Case of Lamotrigine in Bipolar Disorder - Medscape - Sep 10, 2008.